Is XOMA Royalty Corp (XOMA) Halal?

NASDAQ Healthcare United States $359M
✗ NOT HALAL
Confidence: 90/100
XOMA Royalty Corp (XOMA) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 37.1% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. XOMA Royalty Corp operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 37.1%
/ 30%
32.7%
/ 30%
5.3%
/ 30%
33.59%
/ 5%
✗ NOT HALAL
DJIM 37.1%
/ 33%
32.7%
/ 33%
5.3%
/ 33%
33.59%
/ 5%
✗ NOT HALAL
MSCI 53.9%
/ 33%
47.5%
/ 33%
7.7%
/ 33%
33.59%
/ 5%
✗ NOT HALAL
S&P 37.1%
/ 33%
32.7%
/ 33%
5.3%
/ 33%
33.59%
/ 5%
✗ NOT HALAL
FTSE 53.9%
/ 33%
47.5%
/ 33%
7.7%
/ 50%
33.59%
/ 5%
✗ NOT HALAL

Financial Highlights

P/E Ratio
20.7
Forward: 14.1
EPS
$1.46
P/B Ratio
4.3
EV/EBITDA
29.8
EV: $428M
Revenue
$10M
Growth: 57.9%
Beta
0.8
Average volatility
Current Ratio
3.4

Profitability

Gross Margin 96.7%
Operating Margin 15.9%
Net Margin 60.8%
Return on Equity (ROE) 34.1%
Return on Assets (ROA) 2.9%

Cash Flow & Balance Sheet

Operating Cash Flow-$14M
Free Cash Flow-$14M
Total Debt$119M
Debt-to-Equity126.5
Current Ratio3.4
Total Assets$221M

Price & Trading

Last Close$30.53
50-Day MA$26.41
200-Day MA$29.76
Avg Volume411K
Beta0.8
52-Week Range
$18.35
$39.92

About XOMA Royalty Corp (XOMA)

CEO
Mr. Owen P. Hughes Jr.
Employees
14
Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
NASDAQ
Market Cap
$359M
Currency
USD

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is XOMA Royalty Corp (XOMA) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), XOMA Royalty Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is XOMA Royalty Corp's debt ratio?

XOMA Royalty Corp's debt ratio is 37.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 53.9%.

What are XOMA Royalty Corp's key financial metrics?

XOMA Royalty Corp has a market capitalization of $359M, trailing P/E ratio of 20.7, and revenue of $10M. The company maintains a gross margin of 96.7% and a net margin of 60.8%. Return on equity stands at 34.1%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.